PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A herbarium mixture of G. ulmifolia and Tecoma stans (400mg before meals for 90 days) showed decreased waist circumference and fasting glucose compared to placebo [PMID:32955964].
Aqueous extracts from stem bark and leaves decreased oxidative stress in blood cells and prevented doxorubicin-induced cardiotoxicity [PMID:30050650].
Oral administration of a procyanidin fraction from the bark decreased systolic arterial pressure and heart rate in sugar-fed hypertensive rats [PMID:18314282].
Aqueous suspension of ethanolic extract from leaves and flowers protected against NSAID-induced gastric lesions in rats [PMID:17884315].
Ethyl acetate fractions inhibited the replication of bovine herpesvirus 1 (100%) and poliovirus 1 (99%) in cultured cells [PMID:16754999].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 31732089 (2019) — Phytochemicals and biological activities of mutamba (Guazuma ulmifolia Lam.): A review. · Food research international (Ottawa, Ont.)
- 2.PMID: 37178880 (2023) — Potential application of polysaccharide mucilages as a substitute for emulsifiers: A review. · International journal of biological macromolecules
- 3.PMID: 30857825 (2019) — Obtaining a novel mucilage from mutamba seeds exploring different high-intensity ultrasound process conditions. · Ultrasonics sonochemistry
- 4.PMID: 31787395 (2020) — Mutamba (Guazuma ulmifolia Lam.) fruit as a novel source of dietary fibre and phenolic compounds. · Food chemistry
- 5.PMID: 32955964 (2021) — Administration of Herbarium Mixture (Guazuma ulmifolia/Tecoma stans) on Metabolic Profile in Type 2 Diabetes Mellitus Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.